Literature DB >> 11701324

Ten years of protein kinase B signalling: a hard Akt to follow.

D P Brazil1, B A Hemmings.   

Abstract

It is ten years since the publication of three papers describing the cloning of a new proto-oncogene serine/threonine kinase termed protein kinase B (PKB)/Akt. Key roles for this protein kinase in cellular processes such as glucose metabolism, cell proliferation, apoptosis, transcription and cell migration are now well established. The explosion of publications involving PKB/Akt in the past three years emphasizes the high level of current interest in this signalling molecule. This review focuses on tracing the characterization of this kinase, through the elucidation of its mechanism of regulation, to its role in regulating physiological and pathophysiological processes, to our current understanding of the biology of PKB/Akt, and prospects for the future.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701324     DOI: 10.1016/s0968-0004(01)01958-2

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  349 in total

1.  Pdx1 restores beta cell function in Irs2 knockout mice.

Authors:  Jake A Kushner; Jing Ye; Markus Schubert; Deborah J Burks; Matthew A Dow; Carrie L Flint; Sanjoy Dutta; Christopher V E Wright; Marc R Montminy; Morris F White
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  Epithelial mesenchymal interactions, the ECM and limb development.

Authors:  Peter Lonai
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

3.  Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells.

Authors:  Gang Xi; Xinchun Shen; Yashwanth Radhakrishnan; Laura Maile; David Clemmons
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

Review 4.  Programmed cell death and new discoveries in the genetics of parkinsonism.

Authors:  Robert E Burke
Journal:  J Neurochem       Date:  2007-12-10       Impact factor: 5.372

5.  PDGF, bFGF and IGF-I stimulate the proliferation of intervertebral disc cells in vitro via the activation of the ERK and Akt signaling pathways.

Authors:  Harris Pratsinis; Dimitris Kletsas
Journal:  Eur Spine J       Date:  2007-09-01       Impact factor: 3.134

6.  Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia.

Authors:  Qing-Li Wu; Claudia Zierold; Erik A Ranheim
Journal:  Blood       Date:  2009-01-28       Impact factor: 22.113

7.  Non-peptidic substrate-mimetic inhibitors of Akt as potential anti-cancer agents.

Authors:  Katherine J Kayser-Bricker; Matthew P Glenn; Sang Hoon Lee; Said M Sebti; Jin Q Cheng; Andrew D Hamilton
Journal:  Bioorg Med Chem       Date:  2008-09-27       Impact factor: 3.641

8.  High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site.

Authors:  Ricardo M Biondi; David Komander; Christine C Thomas; Jose M Lizcano; Maria Deak; Dario R Alessi; Daan M F van Aalten
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

9.  Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.

Authors:  Christine Kurlawalla-Martinez; Bangyan Stiles; Ying Wang; Sherin U Devaskar; Barbara B Kahn; Hong Wu
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation.

Authors:  Yanlin Yu; Meng Dai; Andrew Lu; Ellen Yu; Glenn Merlino
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.